21/11/2025
*AKD, Off the Analyst's Desk – Nov 21, 2025*
*FEROZ - FY25 & 1QFY26 Analyst Briefing takeaways*
Ferozsons Laboratories Ltd. (FEROZ) held its corporate briefing today to discuss its FY25 & 1QFY26 financial results and future outlook. Following are the key highlights:
To recall, company’s standalone profitability increased by 32%YoY to PkR528mn (EPS: PkR12.2) in FY25 from PkR400mn (EPS: PkR9.2) in SPLY, supported by higher sales and improved gross margins.
In 1QFY26, earnings increased by 30%YoY to PkR182mn (EPS: PkR4.2) from PkR141mn (EPS: PkR3.2) in SPLY.
Company’s revenue increased by 9%YoY in FY25, primarily driven by volumetric growth. Notably, overall pharma industry growth during the year was price-led.
https://research.akdsl.com/638993372892689449.pdf
*Regards*
*AKD Research*